Medanta Share Price (MEDANTA)
Check the latest share price of Medanta, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Medanta Stock Performance
Get live Medanta share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹1,168.1Day's Price Range₹1,190.352 Week's Low
52 Week's High
₹935.552-Week Price Range₹1,388.95
| Returns % | |
| 1 Month Return | -4.59 % |
| 3 Month Return | + 0.56 % |
| 1 Year Return | -7.26 % |
| 3 Year Return | + 185.24 % |
| 5 Year Return | + 185.24 % |
| Market Stats | |
| Previous Close | ₹1,184.60 |
| Open | ₹1,182.00 |
| Volume | 1.30L |
| Upper Circuit | ₹1,421.50 |
| Lower Circuit | ₹947.70 |
Medanta Fundamentals & Key Indicators
Check Medanta market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹31,816.86 Cr
Return on Equity (ROE)
13.52
PE Ratio (TTM)
66.1
Return on capital employed (ROCE)
17.19
Industry PE ratio
102.23
Beta (LTM)
0.7
P/B Ratio
12.48
Dividend Yield
0PEG Ratio
600.95
Quarterly Earnings Growth YOY
-20.39
EPS (TTM)
12.16
Sector
Healthcare
Book Value
90.54
Technical Analysis
Bearish
View Technical Analysis
How to invest in Medanta?
Investing in Medanta is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Medanta or MEDANTA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Medanta or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Medanta with just a few clicks!
Medanta Stock's Interest Amongst Investors
Medanta Valuation
Track how Medanta P/E has moved over time to understand its valuation trends.
Medanta in the last 5 years
Lowest (37.92x)
April 6, 2023
Today (66.10x)
June 12, 2025
Industry (102.23x)
June 12, 2025
Highest (88.30x)
February 23, 2024
Today’s Price to Earnings Ratio: 66.10x
Medanta Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Medanta.
based on 15 analysts
66.67%
Buy
20.00%
Hold
13.33%
Sell
66.67% of analysts recommend a 'BUY' rating for Medanta. Average target price of ₹1273.87
Source: S&P Global Market Intelligence
Medanta Share Price Target
Get share price movements and forecasts by analysts on Medanta.
Medanta price forecast by 15 analysts
Upside of7.54%
High
₹1536
Target
₹1273.87
Low
₹855
Medanta target price ₹1273.87, a slight upside of 7.54% compared to current price of ₹1186. According to 15 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medanta revenue growth forecast
Expected growth rate Q1, FY2027:85.42%
Forecast
Actual
Including amortisation and stock based compensations
Medanta EPS growth forecast
EPS estimate Q1, FY2027:136.02%
Forecast
Actual
Source: S&P Global Market Intelligence
Medanta Financial Results
Get the annual and quarterly financial summary of Medanta, including revenue, profit, loss and more.
Indices Featuring Medanta Stock
Check stock indices that include Medanta.
Medanta Earnings and Dividends
View detailed summary of the earnings and dividend history of Medanta.
Global Health Ltd Earnings Results
Global Health Ltd’s net profit fell -20.4% since last year same period to ₹101.40Cr in the Q4 2024-2025. On a quarterly growth basis, Global Health Ltd has generated -29.05% fall in its net profits since last 3-months.
Read More about Earnings Results
Medanta Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medanta.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 33.03% | 0.00 | |
| Foreign Institutions | 11.76% | 0.00 | |
| Mutual Funds | 10.36% | 0.00 | |
| Retail Investors | 43.28% | 0.00 | |
| Others | 1.57% | 0.00 |
Medanta vs Peers
Compare market cap, revenue, PE, and other key metrics of Medanta with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 31,816.86 | 37.05% | 0.55 | 326 | 2,694 | |
| NA | 51.08 | 68.05% | 0.73 | 1 | 51 | |
| NA | 138.71 | 10.97% | 0.50 | 45 | 59 | |
| NA | 9.32 | 39.79% | 0.58 | -1 | 20 | |
| NA | 449.38 | 5.08% | 1.56 | -130 | 404 |
Medanta News & Key Events
Latest news and events in one place to help you make informed investing decisions in Medanta.
Global Health Ltd Reports Mixed Financial Results - 04 Jun, 2025
Global Health Ltd (MEDANTA) reported an increase in revenue from Rs 808.63 Cr in Mar 2024 to Rs 931.25 Cr in Mar 2025. However, net profit decreased from Rs 127.35 Cr to Rs 101.38 Cr, and EPS fell from Rs 4.74 to Rs 3.77 during the same period.Medanta Plans New Multi-Speciality Hospital in Raipur - 25 May, 2025
Dr. Naresh Trehan announced plans for a state-of-the-art multi-speciality hospital in Raipur, with an investment of approximately Rs 500 crore, featuring advanced medical technology and expert facilities.Emkay Global Maintains REDUCE Rating on Global Health - 20 May, 2025
Emkay Global Financial maintains a REDUCE rating on Global Health (Medanta), raising the target price to Rs 1,175. The company expects flat margins in FY26 due to capacity constraints and execution risks from expansion plans, despite a projected revenue CAGR of 15% from FY25-28E.Global Health Plans Major Expansion with Rs 4,000 Crore Investment - 18 May, 2025
Global Health Ltd, operating under the Medanta brand, plans to invest Rs 4,000 crore to expand its capacity to 6,000 beds, focusing on new hospitals in Noida, Guwahati, and Mumbai. The expansion aims to enhance healthcare services and includes maintenance for existing facilities.Global Health Reports Mixed Q4 Results - 16 May, 2025
Global Health's Q4FY25 results show a 20% decline in PAT to ₹101.4 crore, despite a 15% revenue increase to ₹931.2 crore. Expansion plans include a new 550-bed facility in Noida by FY26.Global Health Reports Mixed Financial Performance - 15 May, 2025
Global Health's net profit declined 20.40% in Q4 FY2025, despite a 15.16% sales increase. Standalone net sales rose 38.75%, and equity shares were allotted under ESOP.
Insights on Global Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 9.00% to 10.36% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 57.4% return, outperforming this stock by 64.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 33.03% of holdings in Mar 2025 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 974.77 Cr → 954.18 Cr (in ₹), with an average decrease of 1.1% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 43.98% to 43.28% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, MEDANTA stock has moved down by -4.6%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 12.47% to 11.76% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 142.91 Cr → 101.4 Cr (in ₹), with an average decrease of 29.1% per quarter
About Medanta
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.
Revenue: ₹931.25Cr as on March 2025 (Q4 FY25)
Net Profit: ₹101.38Cr as on March 2025 (Q4 FY25)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
| Organisation | Global Health Ltd |
| Industry | Healthcare |
| CEO | Naresh Kumar Trehan |
| E-voting on shares | Click here to vote |
Mutual Funds that own Medanta
Check out the Mutual Funds with significant holdings in Medanta.
FAQs
What is Medanta share price today?
Medanta share price today stands at ₹1186, Open: ₹1182, Previous Close: ₹1184.6, High: ₹1190.3, Low: ₹1168.1, 52 Week High: ₹1388.95, 52 Week Low: ₹935.5.
What is today's traded volume of Medanta?
Today's traded volume of Medanta is 1.30L. Which means that 1.30L shares of Medanta were bought and sold on the stock market during today's trading session.
What is Medanta's market cap today?
Today's market capitalisation of Medanta is ₹31,816.86 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Medanta?
Medanta’s 52 week high is ₹1388.95 and 52 week low is ₹935.5. The current share price of Medanta is ₹1186, which is -14.61% down from its 52 week high and 26.78% up from its 52 week low.